Private equity and the transparency tempest in health care

Bobby Guy discusses the growing legislative push to restrict private equity investment in health care and its potential unintended consequences. He draws parallels to the Sarbanes-Oxley Act, arguing that increased regulation of public markets contributed to the rise of private equity by limiting companies’ access to public capital. Bobby cautions that further restrictions on private equity could hinder health care innovation and advocates expanding access to public markets to provide health care companies with more sources of investment.